iACT4CARERS Digital Platform Significantly Reduces Anxiety in Dementia Caregivers

Researchers have identified a new digital platform, iACT4CARERS, that significantly reduces anxiety and depression in family members caring for people with dementia. The intervention, which combines online therapy sessions with minimal support from NHS workers, demonstrated sustained mental health improvements in a national trial led by the University of East Anglia.

iACT4CARERS Trial Results and Accessibility

Family caregivers often face significant barriers to accessing mental health support, including the inability to leave their relatives or the strain on existing care services. Half of the cohort received standard care, while the other half utilized the iACT4CARERS platform, which guides users through eight online sessions focused on managing difficult emotions while maintaining personal health.

The results indicated that the digital intervention provided measurable benefits. Dr. Naoko Kishita, the lead researcher from the University of East Anglia’s School of Health Sciences, noted that participants using the platform experienced lower anxiety levels after three months, with improvements maintained at a six-month follow-up. The improvement wasn’t just statistically significant – it was meaningful in real life, Dr. Kishita said.

The Role of Digital Therapeutics in Neurology and Mental Health

Beyond dementia support, the application of technology in mental health is expanding to include virtual reality and AI-driven diagnostics. Other innovations, such as Olfactory Virtual Reality (OVR), are being explored to trigger memory and cognition in patients dealing with chronic pain and mood disorders.

Simultaneously, London-based startup Mindstep is positioning its app as a one-stop neurology clinic to detect brain health conditions like dementia, anxiety, and depression. According to Sifted, the company recently secured a £2.5m seed round led by Octopus Ventures to further develop its diagnostic capabilities. The app utilizes smartphone-based eye-tracking technology—similar to that used for social media filters—to monitor pupil flickers and facial expressions, which the company claims can identify brain health indicators with same or superior accuracy to traditional methods.

Investment Trends and Regulatory Hurdles

The surge in digital health startups coincides with a broader increase in investor interest. While investment in European mental health startups grew 10-fold over the past two years to reach $1.2bn, Sifted reports that experts still view the field as underfunded relative to the size of the unmet need. Michael Lutolf, an investment manager at Verve Ventures, observed that the market remains in its infancy, stating, It is still a relatively young field, but once there are the first successful cases the funding will definitely rise and investors will finance these companies from seed to IPO.

Digital Separation Anxiety : When Kids Can't Disconnect

Despite the potential, these platforms face rigorous clinical and regulatory paths. Mindstep, for instance, is currently undergoing clinical trials with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). The company expects these trials to conclude in March, with a planned direct-to-consumer launch in September. The ultimate goal for many such startups is to integrate into public health systems, such as the NHS, to ensure free access for patients.

Future Outlook for Clinical Integration

The integration of these technologies into standard care remains a primary objective. Prof. Anthony Gordon, Director for the NIHR Health Technology Assessment (HTA) Programme, emphasized the importance of evaluating these digital tools, noting that their user-friendly and cost-effective nature could support a significant number of people if scaled correctly. The focus now shifts to whether these platforms can maintain their efficacy as they transition from controlled study environments to widespread public adoption.

For Mindstep, the immediate focus is the upcoming MHRA milestone and a planned Series A funding round in early 2023. Meanwhile, the research team behind iACT4CARERS continues to look toward international implementation, citing the platform’s minimal requirement for professional support as a key advantage for global scalability.

Find more reporting in our Health section.

Worth a look